共 50 条
- [1] Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on “Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer—A Phase 3 Clinical Trial” [J]. Annals of Surgical Oncology, 2022, 29 : 3357 - 3358
- [2] Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial [J]. Annals of Surgical Oncology, 2022, 29 : 2617 - 2625
- [4] Letter to the Editor: Comment on ‘‘Cytoreductive Surgery with or without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial’’ [J]. Annals of Surgical Oncology, 2022, 29 : 3351 - 3352
- [7] ASO Visual Abstract: Cytoreductive Surgery with or Without HIPEC after Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase III Clinical Trial [J]. Annals of Surgical Oncology, 2022, 29 : 2628 - 2629
- [9] Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer [J]. Annals of Surgical Oncology, 2022, 29 : 3361 - 3362